JK

Joerg Kaufmann

CH Chiron: 6 patents #94 of 583Top 20%
ND Novartis Vaccines And Diagnostics: 5 patents #65 of 420Top 20%
RO Roche Diagnostics Operations: 1 patents #909 of 1,692Top 55%
ST Sapience Therapeutics: 1 patents #23 of 30Top 80%
Volkswagen: 1 patents #1,423 of 3,450Top 45%
Overall (All Time): #342,592 of 4,157,543Top 9%
14
Patents All Time

Issued Patents All Time

Patent #TitleCo-InventorsDate
11796540 Methods for modulating signal intensity in interaction assays Georg Kurz, Eloisa Lopez-Calle, Ewelina Hegel, Josef Roedl, Eva Hoess +1 more 2023-10-24
11532845 Battery cell Volker Hohm, Bastian Schaar, Frank Wesche, Helge Herten 2022-12-20
9133515 Use of VEGFR1 as a biomarker Klaus Giese 2015-09-15
8236928 Genes differentially expressed in breast cancer Greg Harrowe, Christoph Reinhard, Sanmao Kang 2012-08-07
8221983 Gene products differentially expressed in cancerous cells Vivien Chan, Jaime Escobedo, Pablo Garcia, Rhonda Hansen, Giulia C. Kennedy +5 more 2012-07-17
7867731 HX2004-6 polypeptide expressed in cancerous cells Christoph Reinhard, Anne Jefferson, Vivien Chan, Hong Xin, Giulia C. Kennedy +3 more 2011-01-11
7700359 Gene products differentially expressed in cancerous cells Vivien Chan, Jaime Escobedo, Pablo Garcia, Rhonda Hansen, Giulia C. Kennedy +5 more 2010-04-20
7605246 Genes differentially expressed in breast cancer Greg Harrowe, Christoph Reinhard, Sanmao Kang 2009-10-20
7081517 Genes differentially expressed in breast cancer Greg Harrowe, Christoph Reinhard, Sanmao Kang 2006-07-25
6589745 CIF130 inhibits cell cycle progression 2003-07-08
6566063 Methods for determining metastatic potential of breast cancer cells by detecting GSEF gene product expression Hong Xin, Greg Harrowe 2003-05-20
6423822 Human CIF130 polypeptides 2002-07-23
6303372 cDNA molecule encoding human CIF130 2001-10-16
6174679 CIF150/hTAFII150 is necessary for cell cycle progression 2001-01-16